NCT01223742View on ClinicalTrials.gov

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

NACompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2002

Study Completion Date

December 31, 2006

Conditions
Hepatic Encephalopathy
Interventions
DIETARY_SUPPLEMENT

ACETYL-L-CARNITINE

2 g acetylcarnitine taken orally twice a day.

DRUG

placebo

placebo twice per day

Trial Locations (1)

95126

Cannizzaro Hospital, Catania

All Listed Sponsors
lead

University of Catania

OTHER

NCT01223742 - Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter